Study of stem cells for several short- and long-term illnesses
Part of Bones, joints & muscles, Brain & nervous system, Heart & circulation, Hormones & metabolism, Immune system & allergy, Infections, Kidney & urinary, Lungs & breathing, Mental health, Skin, Women’s health & pregnancy clinical trials.
This early-stage study tests whether injections of mesenchymal stem cells can be safe and helpful for certain chronic (long-term) and acute (short-term) conditions. You might be considered if you can consent, are able to return for follow-up visits, and do not have key reasons that would make stem-cell treatment unsafe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can clearly understand the study and sign the consent form.
- You can come back for follow-up visits during the study.
- You do not have active cancer or cancer treatment in the last 2 years.
- You are not pregnant and not breast-feeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This study tests a new therapy made from donor stem cells that may help repair damaged muscles, bones, tendons, and joints. It is for people whose injuries or degenerative conditions have not healed on their own.
This clinical trial is testing if infusions of special stem cells (called mesenchymal stem cells) can help people with certain autoimmune diseases where standard treatments have not worked well enough. It is an early-phase study in Pakistan for adults (and some children for one condition) with rheumatoid arthritis, lupus, systemic sclerosis, ankylosing spondylitis, or dermatomyositis/polymyositis.
This early study tests whether two types of stem cells—made from your own fat cells versus from donated umbilical-cord cells—are safe when injected into the fluid around the spinal cord. It may help researchers find safer cell-based options for people with spinal cord injury.
This Phase 2 study tests an injected stem cell treatment made from body fat to improve sexual function in women who are in the perimenopause stage (not yet fully through menopause). You may qualify if your hormone and symptom levels suggest decline and you meet general health and infection-safety checks.
This study tests whether stem cells from donated fat tissue can slow down primary progressive multiple sclerosis. You would receive a single injection of the cells into your spinal fluid and be followed for up to 2 years.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.